naltrexone has been researched along with Genetic Predisposition in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Amaral, RA; Castaldelli-Maia, JM; de Antonio, J; de Berardis, D; de Oliveira, ABP; de Toledo Gonçalves, F; Firigato, I; Gattás, GJF; Gonçalves, PD; Malbergier, A; Negrão, AB; Ventriglio, A | 1 |
| Bygum, A; Lindahl, KH; Pallesen, KAU | 1 |
| Derkinderen, P; Grall-Bronnec, M; Laforgue, E; Verholleman, A; Verstuyft, C; Victorri-Vigneau, C | 1 |
| Acevedo-Mackey, D; Acharjee, N; Akhtar, K; Al-Buriahi, MS; Amandi, A; An, Y; Anjum, NA; Asgari, Q; Badiei, B; Baez Vasquez, AY; Bagley, GD; Bahreini, MS; Bajelan, S; Baluja, MQ; Barbieri, MA; Batalha, MA; Bettiol, H; Bhattarai, U; Biset, JC; Bjerg, M; Björnsson, BT; Boag, AM; Borthwick, MS; Boukhris, I; Bragança, MLBM; Breves, JP; Britz-McKibbin, P; Broaddus, RR; Burnell, JE; Camargo, CA; Campo, M; Carlsen, KL; Catchpole, B; Cavalli, L; Chai, C; Chanakya, HN; Chang, AYH; Chantada, A; Chen, W; Chen, X; Chen, Y; Cheng, ZL; Chenoweth, DA; Chhetri, S; Coelho, CCNDS; Coker, ES; Cole, MA; Coniglio, A; Connor, TR; Corbishley, A; D'Arienzo, M; da Silva, AAM; Dai, Y; de Oliveira, BR; Dignac, MF; Dong, A; Dottino, JA; Duo, J; Einarsdottir, IE; Ekanayake, EMDNK; El Fels, L; El Hayany, B; El Shahawy, O; Elliott, RJR; Fabrizi, E; Farkas, K; Fellman, B; Fenoglio, D; Ferrario, M; Flögel, F; Fujiogi, M; Gamage, BD; Ganson, KT; Gao, X; Gärtner, S; Gautam, A; Gautam, S; Gaze, WH; Gosse, JA; Graham, DW; Graham, PA; Guastella, G; Guerrero, S; Gul, M; Guo, B; Guo, X; Gupta, VK; Hafidi, M; Halland, A; Han, W; Hardisty, M; Hasegawa, K; Hess, ST; Heydari, R; Hillary, LS; Holm, R; Huang, L; Jaleh, B; Jayasundara, JASB; Ji, X; Jiang, L; Jones, DL; Kac, G; Kebaili, I; Kelley, JB; Kelum, SHP; Kennedy, LJ; Khan, NA; Khazalpour, S; Khuntia, HK; Kinney, MS; Kommedal, Ø; Koomhin, P; Krawczyk, N; Kæstel, T; Lakmal, MAC; Li, H; Li, K; Li, R; Li, S; Li, W; Li, X; Li, Y; Liang, L; Lin, Y; Lippo, E; Liu, B; Liu, F; Liu, J; Liu, X; Liu, Y; Lodha, D; Loose, DS; López-Meza, P; Lu, F; Lu, KH; Lu, Y; Luo, Y; Ma, B; Malham, SK; Masood, A; Matan, N; McCormick, SD; McDonald, JE; McKenzie, LJ; Melendez, BD; Mikaeili, F; Mir, IR; Mirjalili, MH; Moreno, KP; Moura, IB; Müller, S; Nagata, JM; Nasri, A; Nasrollahzadeh, M; Navarro-Jiménez, E; Nie, E; Nielsen, CU; Nielsen, S; Nøhr, MK; Obeng, B; Odetayo, AA; Ortiz-Barrios, M; Ozgen, C; Pan, X; Parisi, ML; Paskavitz, AL; Patel, AK; Pedersen, M; Pontarollo, N; Potts, CM; Price, C; Pu, Y; Quénéa, K; Rahimi Khonakdari, M; Rather, BA; Raut, P; Regish, AM; Reible, DD; Rezadoost, H; Rizzati, M; Roviello, GN; Roviello, V; Rumpel, C; Sang, J; Sangroula, S; Saraiva, MDCP; Sarker, A; Sayyed, MI; Segoshi, A; Sehar, Z; Shao, X; Shaw, D; Shaw, L; Shekhawat, NS; Shim, JK; Shokouhimehr, M; Short, A; Soliman, PT; Songsamoe, S; Springer-Miller, RH; Stenstad, T; Strobl, E; Sun, R; Syme, H; Thai, L; Tian, G; Tofighi, B; Tonguc, B; Tuyiringire, D; Ulaganathan, N; Ulvestad, E; Varacca, A; Vergalli, S; Verma, DK; Villmones, HC; Wang, D; Wang, H; Wang, J; Wang, L; Wang, M; Wang, S; Wang, Y; Wang, Z; Weedon-Fekjær, H; Weller, SR; West, BE; Wilcox, MH; Wu, W; Wufuer, R; Xia, S; Xiang, H; Xu, H; Yan, L; Yang, RK; Yang, Y; Yates, MS; Ye, Q; Yin, H; Yin, Y; Yuan, Y; Yucesan, M; Yue, W; Zeng, W; Zhang, C; Zhang, D; Zhang, H; Zhang, L; Zhang, Q; Zhang, Y; Zhou, B; Zhou, Y; Zhu, Y; Zhu, Z | 1 |
| Dilley, JE; Filosa, NJ; Fischer, SM; Froehlich, JC; Nicholson, ER; Rademacher, LC; Smith, TN | 1 |
| Anton, RF | 1 |
| Clarke, TK; Schumann, G; Stacey, D | 1 |
| Chin, PF; Miotto, K; Ray, LA | 1 |
| Carr, GD | 1 |
| Kuehn, BM | 1 |
| Lesniak, A; Lipkowski, AW; Ragan, AR; Sacharczuk, M; Sadowski, B; Szymanska, H | 1 |
| Froehlich, JC; O'Malley, SS | 1 |
| Adinoff, B; Junghanns, K; Kiefer, F; Krishnan-Sarin, S | 1 |
| Krishnan-Sarin, S; Krystal, JH; O'Malley, SS; Pittman, B; Shi, J | 1 |
| McGeary, JE; Miranda, R; Monti, PM; Rohsenow, DJ | 1 |
| Diehl, A; Jiménez-Arriero, MA; Kiefer, F; Klein, O; Rubio, G | 1 |
| Capasso, A; Cutrufo, C; Di Giannuario, A; Loizzo, A; Palazzesi, S; Pieretti, S; Sorrentino, L | 1 |
6 review(s) available for naltrexone and Genetic Predisposition
| Article | Year |
|---|---|
Naltrexone Use in Treating Hypersexuality Induced by Dopamine Replacement Therapy: Impact of
Topics: Animals; Disease Susceptibility; Dopamine; Genetic Predisposition to Disease; Genotype; Humans; Naltrexone; Narcotic Antagonists; Parkinson Disease; Polymorphism, Single Nucleotide; Receptors, Opioid, mu; Sexual Dysfunction, Physiological; Sexuality; Treatment Outcome | 2020 |
Topics: Acyclic Monoterpenes; Adipose Tissue; Adolescent; Adult; Aged; Aged, 80 and over; Air Pollutants; Air Pollutants, Occupational; Amino Acid Transport Systems; Analgesics, Opioid; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Arthrobacter; Bacteria; Bacteriological Techniques; Benzaldehydes; Biodegradation, Environmental; Biofilms; Biological Transport; Biomarkers; Biomass; Bioreactors; Body Composition; Body Mass Index; Brassica; Brazil; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Caco-2 Cells; Cadmium; Calcium; Calcium Carbonate; Calcium Channels; Catalysis; Cell Degranulation; Cell Line; Cell Membrane; Chitosan; Chromatography, High Pressure Liquid; Chromium; Cobalt; Cohort Studies; Colony Count, Microbial; Composting; Copper; COVID-19; Cross-Sectional Studies; Cytoplasm; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Diarrhea; Diethylhexyl Phthalate; Dose-Response Relationship, Drug; Drug Implants; Drug Stability; Drug Synergism; Electroplating; Endometrial Neoplasms; Endometrium; Environmental Monitoring; Environmental Restoration and Remediation; Estradiol; Estrogens; Feces; Female; Food Microbiology; Food Preservation; Fruit and Vegetable Juices; Gasotransmitters; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gene Expression Regulation, Developmental; Genetic Predisposition to Disease; Glutathione; Gold; Graphite; Growth Hormone; Harm Reduction; Hot Temperature; Humans; Hydrocortisone; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydrogen-Ion Concentration; Ileum; Imidazoles; Injections, Intraperitoneal; Insecticides; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 5; Insulin-Like Growth Factor I; Intestinal Absorption; Light; Lignin; Liver; Magnetics; Male; Manganese; Mast Cells; Melanoma; Membrane Potentials; Metals; Methadone; Microbial Viability; Microplastics; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Middle Aged; Mitochondrial Swelling; Molecular Dynamics Simulation; Monophenol Monooxygenase; Morocco; Naloxone; Naltrexone; Nanocomposites; Nanomedicine; Nanoparticles; Narcotic Antagonists; Neonicotinoids; Nitric Oxide; Nitro Compounds; Nitrogen; Nitrogen Compounds; Obesity; Obesity, Abdominal; Occupational Exposure; Ontario; Opiate Substitution Treatment; Opioid-Related Disorders; Oryza; Overweight; Oxidative Stress; Oxides; Oxygen; Perception; Photoelectron Spectroscopy; Plants; Plastics; Point Mutation; Polychlorinated Biphenyls; Polycyclic Aromatic Hydrocarbons; Potassium; Premenopause; Prodrugs; Prospective Studies; Protons; Pyrolysis; Qualitative Research; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resins, Synthetic; Rhodamines; Risk Factors; ROC Curve; Salmo salar; SARS-CoV-2; Seawater; Severity of Illness Index; Sewage; Social Media; Soil; Soil Microbiology; Soil Pollutants; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Staining and Labeling; Stainless Steel; Steel; Stress, Physiological; Substance Abuse Treatment Centers; Symporters; T-Lymphocytes; Toluene; Triclosan; Ultraviolet Rays; Waist Circumference; Waste Disposal, Fluid; Wastewater; Water Purification; Welding; X-Ray Diffraction; Young Adult | 2020 |
The genetics of alcoholism.
Topics: Alcoholism; Animals; Corticotropin-Releasing Hormone; Disease Models, Animal; Excitatory Amino Acids; Genetic Predisposition to Disease; Humans; Mice; Naltrexone; Narcotic Antagonists; Rats; Receptors, Corticotropin-Releasing Hormone; Receptors, Opioid, mu; Social Environment; Stress, Psychological | 2009 |
Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics.
Topics: Alcohol-Induced Disorders, Nervous System; Alcoholism; Brain; Brain Chemistry; Genetic Predisposition to Disease; Humans; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu | 2010 |
Alcoholism: a modern look at an ancient illness.
Topics: Alcoholism; Genetic Predisposition to Disease; Humans; Naltrexone; Narcotic Antagonists; Primary Health Care; Risk Factors; Secondary Prevention; Selective Serotonin Reuptake Inhibitors | 2011 |
Advances in the use of naltrexone: an integration of preclinical and clinical findings.
Topics: Alcohol Deterrents; Alcoholism; Genetic Predisposition to Disease; Humans; Motivation; Naltrexone; Narcotic Antagonists; Randomized Controlled Trials as Topic; Recurrence | 2003 |
2 trial(s) available for naltrexone and Genetic Predisposition
| Article | Year |
|---|---|
Exploring the Role of Alcohol Metabolizing Genotypes in a 12-Week Clinical Trial of Naltrexone for Alcohol Use Disorder.
Topics: Alcoholism; Ethanol; Female; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Naltrexone; Polymorphism, Single Nucleotide; Treatment Outcome | 2021 |
Family history and antisocial traits moderate naltrexone's effects on heavy drinking in alcoholics.
Topics: Adult; Age of Onset; Alcohol Drinking; Alcoholism; Antisocial Personality Disorder; Cocaine-Related Disorders; Comorbidity; Double-Blind Method; Family; Female; Genetic Predisposition to Disease; Humans; Male; Marijuana Abuse; Naltrexone | 2007 |
9 other study(ies) available for naltrexone and Genetic Predisposition
| Article | Year |
|---|---|
Dominant Dystrophic Epidermolysis Bullosa Pruriginosa Responding to Naltrexone Treatment.
Topics: Adult; Child; Collagen Type VII; Epidermolysis Bullosa Dystrophica; Genetic Predisposition to Disease; Heredity; Humans; Male; Mutation; Naltrexone; Narcotic Antagonists; Phenotype; Skin; Treatment Outcome | 2019 |
A Combination of Naltrexone + Varenicline Retards the Expression of a Genetic Predisposition Toward High Alcohol Drinking.
Topics: Alcohol Drinking; Animals; Drug Therapy, Combination; Genetic Predisposition to Disease; Male; Naltrexone; Narcotic Antagonists; Nicotinic Agonists; Rats; Varenicline | 2017 |
Genetic basis for predicting response to naltrexone in the treatment of alcohol dependence.
Topics: Alcoholism; Genetic Markers; Genetic Predisposition to Disease; Humans; Naltrexone; Narcotic Antagonists; Treatment Outcome | 2008 |
Study suggests gene may predict success of therapies for alcohol dependence.
Topics: Alcoholism; Genetic Predisposition to Disease; Humans; Naltrexone; Narcotic Antagonists; Ondansetron; Predictive Value of Tests; Receptors, Opioid, mu; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Treatment Outcome | 2011 |
Distinct susceptibility to inoculated melanoma and sensitivity to cancer pain in mouse lines with high and low sensitivity to stress.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Genetic Predisposition to Disease; Genotype; Hyperalgesia; Male; Melanoma; Mice; Models, Animal; Naltrexone; Narcotic Antagonists; Opioid Peptides; Skin Neoplasms; Stress, Physiological; Swimming | 2012 |
Suppression of the HPA axis stress-response: implications for relapse.
Topics: Adrenocorticotropic Hormone; Alcoholism; Arousal; Drive; Genetic Predisposition to Disease; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Naltrexone; Pituitary-Adrenal System; Recurrence; Risk | 2005 |
Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking.
Topics: Adult; Alcohol Drinking; Alcoholism; Behavior, Addictive; Choice Behavior; Dose-Response Relationship, Drug; Family; Female; Genetic Predisposition to Disease; Humans; Male; Naltrexone; Narcotic Antagonists; Reward; Sex Factors; Treatment Outcome | 2007 |
Cloninger's typology and treatment outcome in alcohol-dependent subjects during pharmacotherapy with naltrexone.
Topics: Acamprosate; Adult; Alcohol Deterrents; Alcoholism; Combined Modality Therapy; Double-Blind Method; Female; Follow-Up Studies; Genetic Predisposition to Disease; Germany; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Patient Compliance; Psychotherapy; Randomized Controlled Trials as Topic; Recurrence; Spain; Taurine; Treatment Outcome | 2008 |
Opioids and corticosteroids involvement in the regulation of the neocortical spindling episodes in DBA/2J mice.
Topics: Adrenal Cortex; Animals; Cerebral Cortex; Corticosterone; Cycloheximide; Dexamethasone; Disease Models, Animal; Disease Susceptibility; Electroencephalography; Epilepsy; Genetic Predisposition to Disease; Male; Mice; Mice, Inbred DBA; Mifepristone; Morphine; Naltrexone | 1993 |